Skip to content

Exploring the Effect of Rumination-Focused Cognitive Behaviour Therapy in Patients With Schizophrenia

Exploring the Effect of Rumination-Focused Cognitive Behaviour Therapy on Depressive Symptoms in Patients With Schizophrenia: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04442893
Enrollment
85
Registered
2020-06-23
Start date
2019-07-22
Completion date
2020-03-16
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Randomized Controlled Trial

Keywords

Rumination-Focused Cognitive Behaviour Therapy(RFCBT), depressive symptom, Schizophrenia

Brief summary

This study will explore the effect of Rumination-Focused Cognitive Behaviour Therapy on depressive symptoms in patients with schizophrenia for three months. A randomized controlled trial is conducted in a psychiatric center in northern Taiwan. All participants are randomized to two groups using blocked randomization. The experimental groups are provided with a 6- session RFCBT program for 12 weeks (60-90 mins, once every two weeks), while the control groups receive a 6- session Health Education program for 12 weeks (60-90 mins, once every two weeks). All participants who suffered from depressive symptoms at both baseline and 3-month follow-up will be evaluated using the Beck Depression Inventory(BDI-II), Chinese Response Style Questionnaire-short form revised(CRSQ-10), Internalized Stigma of Mental Illness (ISMI) Scale, and Herth Hope Index Chinese Version(HHI).

Detailed description

Background: Depressive symptoms are one of the core symptoms in patients with schizophrenia, but the effect of depressive symptoms on patients is easily overlooked. Severe depressive symptoms in patients with schizophrenia are not only affecting the quality of life but also the risk factors of suicide. Aim: The investigators hypothesize that Rumination-Focused Cognitive Behaviour Therapy(RFCBT) could have significant effect of depressive symptoms. Therefore, in this study, the investigators will explore the effect of Rumination-Focused Cognitive Behaviour Therapy(RFCBT) on depressive symptoms in patients with schizophrenia. Methods: The study is conducted as a two-arm, single-blinded, randomized controlled trial in a psychiatric center in northern Taiwan. Participants are randomly allocated in a 1:1 ratio to two groups using blocked randomization. The experimental groups are provided with a 6- session RFCBT program for 12 weeks (60-90 mins, once every two weeks), while the control groups receive a 6- session Health Education program for 12 weeks (60-90 mins, once every two weeks) . Participants and demographic data: Participants who have been diagnosed with schizophrenia according to DSM-IV criteria took part in the study after informed consent is obtained. All participants are 20 years of age or older and are receiving a stable dosage of antipsychotics, and have no history of cognitive impairment. The participants are able to express themselves and to individually complete the Beck Depression Inventory(BDI-II), Chinese Response Style Questionnaire-short form revised(CRSQ-10), Internalized Stigma of Mental Illness (ISMI) Scale, and Herth Hope Index Chinese Version(HHI). Measures: The demographic characteristics include five continuous variables (age, age at onset, duration of disease, years of education, chlorpromazine equivalent dose (Andreasen, Pressler, Nopoulos, Miller, & Ho, 2010) and four categorical variables (sex, marital status, work status, antidepressants). Procedure and Data collection: All procedures are approved by both national Ying Ming university(IRB YM108038F) and the psychiatric center (IRB 1080009-01). Following informed consent, each participant will fill out a demographic questionnaire and complete the BDI-II, CRHQ-10, ISMIS, and HHI once at baseline and twice an interval of three months. A well-trained and licensed psychiatric nurse will perform the data collection and assists the participants if there were difficulties reading or understanding the questionnaires. Statistical analysis: This study will employ Predictive Analytics Suite Workstation (IBM SPSS 24.0) to analyze the collected data. The data analyses will include demographic variables and the scores of BDI-II, CRHQ-10, ISMIS, and HHI at the interval of three months of all of the participants.

Interventions

BEHAVIORALRumination-Focused Cognitive Behaviour Therapy

Rumination-Focused Cognitive Behavioural Therapy(RFCBT) is based on a differentiation between functional and dysfunctional styles of perseverative thinking with the helpful style characterized as a concrete, process-focused and specific style of thinking and the idea that rumination is a habit maintained by negative reinforcement. In line with the theoretical assumptions, RFCBT combines strategies from behavioral activation with strategies to foster concrete, process-focused and specific thinking.

Health education programme would be any planned activity or set of activities aimed at increasing health literacy and developing life skills conducing to health (e.g. decision making, problem solving, critical thinking, interpersonal skills, stress management, coping with emotions).

Sponsors

Bali Psychiatric Center
CollaboratorOTHER
National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

The data of PANSS were collected by a research assistant.

Intervention model description

The participants were divided into experimental and control groups through block randomization

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* The participants are diagnosed with schizophrenia by Diagnostic and Statistical Manual of Mental Disorders, Five Edition (DSM-V), an age of between 20 and 65 years, hospitalization in a rehabilitation unit, and a stable condition at the time of data collection. * The participants are able to provide written informed consent and comprehend the instruments. * The participants consent to receive a 6- session RFCBT program or a 6- session Health Education program and complete a package of questionnaires. * The participants are satisfied the screening criteria including the Positive and Negative Syndrome Scale (PANSS) for positive syndromes \< 5, the Mini-Mental State Examination (MMSE) ≥ 24, and the Brief Symptom Rating Scale (BSRS-5) ≥ 6.

Exclusion criteria

* The participants who have intellectual disturbances (organic mental disorders) or substance abuse issues through a chart review. * The participants who are not willing to sign the consent.

Design outcomes

Primary

MeasureTime frameDescription
Beck Depression Inventory (BDI-II)For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).The Beck Depression Inventory-II (BDI-II) is a 21-item self-report depression screening measure. Each item is rated on a four-point Likert-type scale ranging from 0 to 3, which with possible scores ranging from 0 to 63. The BDI-II has been translated into a Chinese version. Higher total scores indicate more severe depressive symptoms, and a score of \>16 points is considered suggestive of the presence of clinically significant depressive symptom intensity. In this study, the investigators will explore the change of BDI-II score among baseline, after intervention and three-month follow-up.
Chinese Response Style Questionnaire-short Form Revised (CRSQ-10)For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).The Chinese Response Style Questionnaire-short form revised (CRSQ-10) is a self-report measure of rumination, comprising ten items and describing the factors of brooding and reflection. Each item is rated on a four-point Likert-type scale ranging from 1 (strongly disagree) to 4 (strongly agree), which with possible scores ranging from 10 to 40. The CRSQ-10 has been used to evaluate the intensity of ruminative responses to depressed mood. In this study, the investigators will explore the change of CRSQ-10 score among baseline, after intervention and three-month follow-up.

Secondary

MeasureTime frameDescription
The Internalized Stigma of Mental Illness (ISMI) ScaleFor two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).The Internalized Stigma of Mental Illness (ISMI) Scale is a 29-item self-report questionnaire measuring self-stigma among persons with psychiatric disorders. Each item is rated on a four-point Likert scale from 1 (strongly disagree) to 4 (strongly agree), which with possible scores ranging from 29 to 116. The ISMI Scale has been translated into a Chinese version. Higher scores indicating greater self-stigma. In this study, the investigators will explore the change of ISMI Scale score among baseline, after intervention and three-month follow-up.
Herth Hope Index Chinese Version(HHI)For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).The Herth Hope Index (HHI) comprises 12-item self-report measure of hopefulness. Each item is rated on a four-point Likert scale from 1 (strongly disagree) to 4 (strongly agree), which with possible scores ranging from 12 to 48. The HHI has been translated into a Chinese version. Higher scores indicating greater hopefulness. In this study, the investigators will explore the change of HHI score among baseline, after intervention and three-month follow-up.

Countries

Taiwan

Participant flow

Participants by arm

ArmCount
Experimental Group
The experimental group would be provided with a 6- session RFCBT program for 12 weeks (60-90 mins, once every two weeks). Rumination-Focused Cognitive Behaviour Therapy: Rumination-Focused Cognitive Behavioural Therapy(RFCBT) is based on a differentiation between functional and dysfunctional styles of perseverative thinking with the helpful style characterized as a concrete, process-focused and specific style of thinking and the idea that rumination is a habit maintained by negative reinforcement. In line with the theoretical assumptions, RFCBT combines strategies from behavioral activation with strategies to foster concrete, process-focused and specific thinking.
44
Control Group
The control group would receive a 6- session Health Education program for 12 weeks (60-90 mins, once every two weeks) Health Education programme: Health education programme would be any planned activity or set of activities aimed at increasing health literacy and developing life skills conducing to health (e.g. decision making, problem solving, critical thinking, interpersonal skills, stress management, coping with emotions).
41
Total85

Baseline characteristics

CharacteristicTotalExperimental GroupControl Group
Age, Continuous51.21 years
STANDARD_DEVIATION 7.93
51.18 years
STANDARD_DEVIATION 7.88
51.24 years
STANDARD_DEVIATION 8.09
Antidepressant users
No
73 Participants39 Participants34 Participants
Antidepressant users
Yes
12 Participants5 Participants7 Participants
CPZ equivalent doses488.11 mg
STANDARD_DEVIATION 272.26
503.77 mg
STANDARD_DEVIATION 260.58
471.29 mg
STANDARD_DEVIATION 286.56
Duration of disease27.93 years
STANDARD_DEVIATION 8.58
29.05 years
STANDARD_DEVIATION 8.43
26.73 years
STANDARD_DEVIATION 8.68
Marital status
Married
14 Participants8 Participants6 Participants
Marital status
Single
71 Participants36 Participants35 Participants
Race and Ethnicity Not Collected0 Participants
Religious preference
Buddha/Christian/other
72 Participants39 Participants33 Participants
Religious preference
None
13 Participants5 Participants8 Participants
Sex: Female, Male
Female
43 Participants21 Participants22 Participants
Sex: Female, Male
Male
42 Participants23 Participants19 Participants
Work status
Employed
26 Participants11 Participants15 Participants
Work status
Not employed
59 Participants33 Participants26 Participants
Year of Education11.54 years
STANDARD_DEVIATION 2.89
11.68 years
STANDARD_DEVIATION 2.88
11.39 years
STANDARD_DEVIATION 2.91

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 440 / 41
other
Total, other adverse events
0 / 440 / 41
serious
Total, serious adverse events
0 / 440 / 41

Outcome results

Primary

Beck Depression Inventory (BDI-II)

The Beck Depression Inventory-II (BDI-II) is a 21-item self-report depression screening measure. Each item is rated on a four-point Likert-type scale ranging from 0 to 3, which with possible scores ranging from 0 to 63. The BDI-II has been translated into a Chinese version. Higher total scores indicate more severe depressive symptoms, and a score of \>16 points is considered suggestive of the presence of clinically significant depressive symptom intensity. In this study, the investigators will explore the change of BDI-II score among baseline, after intervention and three-month follow-up.

Time frame: For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).

ArmMeasureGroupValue (MEAN)Dispersion
Experimental GroupBeck Depression Inventory (BDI-II)T016.89 score on a scaleStandard Deviation 12.32
Experimental GroupBeck Depression Inventory (BDI-II)T116.60 score on a scaleStandard Deviation 10.8
Experimental GroupBeck Depression Inventory (BDI-II)T215.56 score on a scaleStandard Deviation 11.26
Control GroupBeck Depression Inventory (BDI-II)T016.88 score on a scaleStandard Deviation 14.63
Control GroupBeck Depression Inventory (BDI-II)T118.70 score on a scaleStandard Deviation 12.88
Control GroupBeck Depression Inventory (BDI-II)T223.03 score on a scaleStandard Deviation 14.81
Primary

Chinese Response Style Questionnaire-short Form Revised (CRSQ-10)

The Chinese Response Style Questionnaire-short form revised (CRSQ-10) is a self-report measure of rumination, comprising ten items and describing the factors of brooding and reflection. Each item is rated on a four-point Likert-type scale ranging from 1 (strongly disagree) to 4 (strongly agree), which with possible scores ranging from 10 to 40. The CRSQ-10 has been used to evaluate the intensity of ruminative responses to depressed mood. In this study, the investigators will explore the change of CRSQ-10 score among baseline, after intervention and three-month follow-up.

Time frame: For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).

ArmMeasureGroupValue (MEAN)Dispersion
Experimental GroupChinese Response Style Questionnaire-short Form Revised (CRSQ-10)T026.25 score on a scaleStandard Deviation 6.75
Experimental GroupChinese Response Style Questionnaire-short Form Revised (CRSQ-10)T126.46 score on a scaleStandard Deviation 5.77
Experimental GroupChinese Response Style Questionnaire-short Form Revised (CRSQ-10)T227.38 score on a scaleStandard Deviation 5.64
Control GroupChinese Response Style Questionnaire-short Form Revised (CRSQ-10)T026.51 score on a scaleStandard Deviation 6.62
Control GroupChinese Response Style Questionnaire-short Form Revised (CRSQ-10)T126.68 score on a scaleStandard Deviation 5.44
Control GroupChinese Response Style Questionnaire-short Form Revised (CRSQ-10)T225.33 score on a scaleStandard Deviation 5.01
Secondary

Herth Hope Index Chinese Version(HHI)

The Herth Hope Index (HHI) comprises 12-item self-report measure of hopefulness. Each item is rated on a four-point Likert scale from 1 (strongly disagree) to 4 (strongly agree), which with possible scores ranging from 12 to 48. The HHI has been translated into a Chinese version. Higher scores indicating greater hopefulness. In this study, the investigators will explore the change of HHI score among baseline, after intervention and three-month follow-up.

Time frame: For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).

ArmMeasureGroupValue (MEAN)Dispersion
Experimental GroupHerth Hope Index Chinese Version(HHI)T033.86 score on a scaleStandard Deviation 6.23
Experimental GroupHerth Hope Index Chinese Version(HHI)T135.00 score on a scaleStandard Deviation 6.35
Experimental GroupHerth Hope Index Chinese Version(HHI)T234.71 score on a scaleStandard Deviation 6.62
Control GroupHerth Hope Index Chinese Version(HHI)T033.54 score on a scaleStandard Deviation 4.35
Control GroupHerth Hope Index Chinese Version(HHI)T132.62 score on a scaleStandard Deviation 6.09
Control GroupHerth Hope Index Chinese Version(HHI)T232.17 score on a scaleStandard Deviation 6.81
Secondary

The Internalized Stigma of Mental Illness (ISMI) Scale

The Internalized Stigma of Mental Illness (ISMI) Scale is a 29-item self-report questionnaire measuring self-stigma among persons with psychiatric disorders. Each item is rated on a four-point Likert scale from 1 (strongly disagree) to 4 (strongly agree), which with possible scores ranging from 29 to 116. The ISMI Scale has been translated into a Chinese version. Higher scores indicating greater self-stigma. In this study, the investigators will explore the change of ISMI Scale score among baseline, after intervention and three-month follow-up.

Time frame: For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).

ArmMeasureGroupValue (MEAN)Dispersion
Experimental GroupThe Internalized Stigma of Mental Illness (ISMI) ScaleT071.86 score on a scaleStandard Deviation 11.33
Experimental GroupThe Internalized Stigma of Mental Illness (ISMI) ScaleT171.52 score on a scaleStandard Deviation 12.43
Experimental GroupThe Internalized Stigma of Mental Illness (ISMI) ScaleT269.12 score on a scaleStandard Deviation 12.83
Control GroupThe Internalized Stigma of Mental Illness (ISMI) ScaleT270.44 score on a scaleStandard Deviation 10.08
Control GroupThe Internalized Stigma of Mental Illness (ISMI) ScaleT068.63 score on a scaleStandard Deviation 11.53
Control GroupThe Internalized Stigma of Mental Illness (ISMI) ScaleT170.35 score on a scaleStandard Deviation 10.29

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026